Matches in Wikidata for { <http://www.wikidata.org/entity/Q82770166> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q82770166 description "artículu científicu espublizáu n'avientu de 2011" @default.
- Q82770166 description "im Dezember 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q82770166 description "scientific article published on 01 December 2011" @default.
- Q82770166 description "wetenschappelijk artikel" @default.
- Q82770166 description "наукова стаття, опублікована в грудні 2011" @default.
- Q82770166 name "Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study" @default.
- Q82770166 name "Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study" @default.
- Q82770166 type Item @default.
- Q82770166 label "Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study" @default.
- Q82770166 label "Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study" @default.
- Q82770166 prefLabel "Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study" @default.
- Q82770166 prefLabel "Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study" @default.
- Q82770166 P1433 Q82770166-2710890C-B785-4C7E-8090-220F2571E0CA @default.
- Q82770166 P1476 Q82770166-4F306F03-3C65-4D15-9470-B2D31C9CF123 @default.
- Q82770166 P2093 Q82770166-17E85BAC-677E-4A0F-A01D-B0434097DC47 @default.
- Q82770166 P2093 Q82770166-48B8CB5B-1362-4BB8-8E05-BF24D021AD7A @default.
- Q82770166 P304 Q82770166-9B99C266-07B2-43BF-82D5-3FD6E5583722 @default.
- Q82770166 P31 Q82770166-C8041885-7C63-4AED-AFC3-7CE4624F0C6B @default.
- Q82770166 P433 Q82770166-5B644D07-C8AF-4AEF-9A52-AABAADC34D80 @default.
- Q82770166 P478 Q82770166-8A020423-B52D-4451-A51E-90FC13A6073F @default.
- Q82770166 P577 Q82770166-7938FB6A-FC92-4D5C-8245-5A96B2A00504 @default.
- Q82770166 P698 Q82770166-DF396A25-5EB9-47B8-BE0B-6A0B296E70DA @default.
- Q82770166 P921 Q82770166-0D25BAF7-2815-4AA3-BE53-C2DBFAC35B4F @default.
- Q82770166 P698 22134562 @default.
- Q82770166 P1433 Q25380091 @default.
- Q82770166 P1476 "Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study" @default.
- Q82770166 P2093 "Alessandra B Alió Sáenz" @default.
- Q82770166 P2093 "Lawrence F Eichenfield" @default.
- Q82770166 P304 "1382-1396" @default.
- Q82770166 P31 Q13442814 @default.
- Q82770166 P433 "12" @default.
- Q82770166 P478 "10" @default.
- Q82770166 P577 "2011-12-01T00:00:00Z" @default.
- Q82770166 P698 "22134562" @default.
- Q82770166 P921 Q422273 @default.